Psychiatry of Transition in a World in Transition
NCT04333797, Not applicable, Completed, Queen Fabiola Children's University Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Psychiatry of Transition in a World in Transition | ClinicalTrials.gov |
| NCT number | NCT04333797 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 252 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Queen Fabiola Children's University Hospital | ClinicalTrials.gov |
| Conditions | Transitional Care, Mental Disorder in Adolescence, Mental Health | ClinicalTrials.gov |
| Interventions | Risk and Protective Factors Assessment | ClinicalTrials.gov |
| First posted | 2020-04-03 | ClinicalTrials.gov |
| Last updated | 2026-01-07 | ClinicalTrials.gov |
Registered outcomes 20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change from Baseline self-rated mental health status (need for care) at 2 years | Change from Baseline HoNOSCA before transition at 17 y.o. to after transition at 19 y.o. | Measured at baseline (T0) and follow-up (T1) with the Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA). | ClinicalTrials.gov |
| Primary | Change from Baseline self-rated measure of quality of life at 2 years | Change from Baseline WHO-QoL before transition at 17 y.o. to after transition at 19 y.o | Measured at baseline (T0) and follow-up (T1) with the Quality of life assessed by World Health Organisation Quality of Life Assessment (WHO-QoL-BREF) | ClinicalTrials.gov |
| Secondary | Self-rated measure of traumatic life events | Before transition at 17 y.o. (T0) | Measured with Childhood Trauma Questionnaire (CTQ) | ClinicalTrials.gov |
| Secondary | Self-rated measure of family functioning | Before transition at 17 y.o. (T0) | Measured with Family Assessment Device (FAD) | ClinicalTrials.gov |
| Secondary | Self-rated measure to quantify the risk of developing psychiatric disorders | Before transition at 17 y.o. (T0) | Measured with General Health Questionnaire (GHQ-12) | ClinicalTrials.gov |
| Secondary | Self-rated measure of internalising and externalising symptoms | Before transition at 17 y.o. (T0) | Measured with Youth Self Report 11-18 (YSR) | ClinicalTrials.gov |
| Secondary | Self-rated measure of impulsivity and compulsivity | Before transition at 17 y.o. (T0) | Measured with Barratt Impulsiveness Scale (BIS-11) | ClinicalTrials.gov |
| Secondary | Self-rated measure of depressivity | Before transition at 17 y.o. (T0) | Measured with Beck Depression Inventory-II (BDI-II) | ClinicalTrials.gov |
| Secondary | Self-rated measure of suicidal risk | Before transition at 17 y.o. (T0) | Measured with Beck Scale of Suicide Ideation (BSS) | ClinicalTrials.gov |
| Secondary | Self-rated measure of emotional regulation | Before transition at 17 y.o. (T0) | Measured with Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA) | ClinicalTrials.gov |
| Secondary | Self-rated measure of interpersonal relationships social adaptation | Before transition at 17 y.o. (T0) | Measured with Social Adaptation Self-evaluation Scale (SASS) | ClinicalTrials.gov |
| Secondary | Self-rated measure of cognitive insight | Before transition at 17 y.o. (T0) | Measured with Beck Cognitive Insight Scale (BCIS) | ClinicalTrials.gov |
| Secondary | Cognitive assessment - IQ | Before transition at 17 y.o. (T0) | Measured with Wechsler Adult Intelligence Scale (WAIS-IV) | ClinicalTrials.gov |
| Secondary | Executive functions assessment - alertness, divided attention, flexibility and working memory | Before transition at 17 y.o. (T0) | Measured with Test of Attentional Performance (TAP) | ClinicalTrials.gov |
| Secondary | Executive functions assessment - cognitive inhibition | Before transition at 17 y.o. (T0) | Measured with STROOP Task | ClinicalTrials.gov |
| Secondary | Executive functions assessment - planning task | Before transition at 17 y.o. (T0) | Measured with Tower of London Test (TOL) | ClinicalTrials.gov |
| Secondary | Self-rated measure of executive functions | Before transition at 17 y.o. (T0) | Measured with Behavior Rating Inventory of Executive Function - Self report (BRIEF-SR) | ClinicalTrials.gov |
| Secondary | Self-rated measure of transition readiness and appropriateness | Before transition at 17 y.o. (T0) | Measured with Transition Readiness and Appropriateness Mesure (TRAM) | ClinicalTrials.gov |
| Secondary | Self-rated measure of therapeutic alliance | After transition at 19 y.o. (T1) | Measured with Helping Alliance Questionnaire (HAQ) | ClinicalTrials.gov |
| Secondary | Self-rated measure of transition related outcomes | After transition at 19 y.o. (T1) | Measured with Transition Related Outcomes Mesure (TROM) | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 40
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 2034749 | BACKGROUND | PubMed |
| 6125971 | BACKGROUND | PubMed |
| 8312295 | BACKGROUND | PubMed |
| 8778124 | BACKGROUND | PubMed |
| 9055514 | BACKGROUND | PubMed |
| 9169311 | BACKGROUND | PubMed |
| 10616607 | BACKGROUND | PubMed |
| 12860775 | BACKGROUND | PubMed |
| 15085902 | BACKGROUND | PubMed |
| 15099613 | BACKGROUND | PubMed |
| 15939837 | BACKGROUND | PubMed |
| 17249634 | BACKGROUND | PubMed |
| 17551351 | BACKGROUND | PubMed |
| 18026842 | BACKGROUND | PubMed |
| 18573214 | BACKGROUND | PubMed |
| 19002191 | BACKGROUND | PubMed |
| 19417667 | BACKGROUND | PubMed |
| 20884954 | BACKGROUND | PubMed |
| 21334565 | BACKGROUND | PubMed |
| 21652063 | BACKGROUND | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Tower Planning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)